NanoViricides Inc. (NNVC)

[changes_iv]

I disagree, but then I am vested on the success of this company. My opinion is obviously biased. I have seen NNVC progressively constructing a path to the clinical trials since 2011 when they contracted BCG for the preparation and submission of Investigational New Drug (IND) applications to the US FDA.

NanoViricides, Inc. (NNVC)is pioneering with their "transformational-technology". The US FDA is providing guidance beyond their documents. If injectable FluCide is not toxic then we only have to reach the human trials by mid-2014 and prove to the world we have an effective drug to effectively combat all strains of influenza, avoid the potentially fatal "cytokine storm" and progressively bring it to an end in a matter of hours, a day, two days.

You may want to read ZincFinger's posts 74459, 74460 and 74462 for more reasons as to why we should cut NanoViricides, Inc. some slack, now that they are on-track.

Once the "railway to the human trials" is complete with the first candidate, broad-spectrum injectable FluCide, the other candidates will roll down those tracks with greater ease, speed, through the human trials and FDA review to market. Confidence is high on Nanoviricides, Inc.!

"...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.

"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.